SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-21-004630
Filing Date
2021-06-30
Accepted
2021-06-30 17:15:18
Documents
12
Period of Report
2021-06-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_063021.htm   iXBRL 8-K 18574
  Complete submission text file 0001171843-21-004630.txt   188824

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE anik-20210624.xsd EX-101.SCH 2784
3 XBRL LABEL FILE anik-20210624_lab.xml EX-101.LAB 34592
4 XBRL PRESENTATION FILE anik-20210624_pre.xml EX-101.PRE 22729
5 EXTRACTED XBRL INSTANCE DOCUMENT f8k_063021_htm.xml XML 3492
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 211062780
SIC: 3841 Surgical & Medical Instruments & Apparatus